APIChangelogInfo
Memorial Day Sale Sale until May 28! Get 15% off! API Price increases May 28th so lock in at a lower rate!
Common stock only
S&P 500 only
Director Only
10% Owner Only

Trans Codes

Select...
Amount
-
Stock
Insider transactions
PASSAGE BIO
tastytradeTrade PASG
PASG Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25-808162432400300k600k900k1 200k1 500k1 800k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-04-24
2025-04-24
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-68,195
$0.00
1
$18.71M
2025-04-23
2025-04-24
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-89,328
$0.00
1
$18.71M
2025-04-22
2025-04-24
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-78,049
$0.00
1
$18.71M
2025-04-17
2025-04-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-77,090
$0.00
1
$18.71M
2025-04-16
2025-04-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-61,638
$0.00
1
$18.71M
2025-04-15
2025-04-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-10,326
$0.00
1
$18.71M
2025-04-15
2025-04-15
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-787K
$0.00
1
$18.71M
2025-03-15
2025-03-18
BORTHWICK KATHLEEN
CFO
A - Grant
Employee Stock Option (right to buy)
278K
$0.00
1
$18.71M
2025-03-15
2025-03-18
CALE EDGAR
GC & CORPORATE SECRETARY
A - Grant
Employee Stock Option (right to buy)
278K
$0.00
1
$18.71M
2025-03-15
2025-03-18
CHOU WILLIAM
PRESIDENT AND CEO
A - Grant
Employee Stock Option (right to buy)
780K
$0.00
1
$18.71M
2025-02-11
2025-02-12
BORTHWICK KATHLEEN
CFO
S - Sale
Common Stock
-3,183
$1.00
-3,183
1
$18.71M
2025-02-10
2025-02-12
BORTHWICK KATHLEEN
CFO
M - Exercise
Common Stock
8,000
1
$18.71M
2025-02-10
2025-02-12
BORTHWICK KATHLEEN
CFO
M - Exercise
Restricted Stock Unit
-8,000
$0.00
1
$18.71M
2025-01-14
2025-01-14
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-79,024
$1.00
-79,024
1
$18.71M
2025-01-13
2025-01-14
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-17,986
$1.00
-17,986
1
$18.71M
2025-01-10
2025-01-14
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-126K
$1.00
-126K
1
$18.71M
2025-01-08
2025-01-08
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-75,007
$1.00
-75,007
1
$18.71M
2025-01-07
2025-01-08
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-52,536
$1.00
-52,536
1
$18.71M
2025-01-06
2025-01-08
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-19,481
$1.00
-19,481
1
$18.71M
2025-01-06
2025-01-06
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-1.14M
$1.00
-1.14M
1
$18.71M
2024-12-27
2024-12-31
LYNX1 CAPITAL MANAGEMENT LP
P - Purchase
Common stock, $0.0001 par value per share
374K
$1.00
374K
1
$18.71M
2024-12-20
2024-12-26
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-230K
$1.00
-230K
1
$18.71M
2024-12-11
2024-12-11
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-80
$1.00
-80
1
$18.71M
2024-12-10
2024-12-11
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-8,015
$1.00
-8,015
1
$18.71M
2024-12-09
2024-12-11
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-54,181
$1.00
-54,181
1
$18.71M
2024-12-06
2024-12-06
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-20,903
$1.00
-20,903
1
$18.71M
2024-12-04
2024-12-06
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-76,200
$1.00
-76,200
1
$18.71M
2024-12-04
2024-12-04
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-2.99M
$1.00
-2.99M
1
$18.71M
2024-12-04
2024-12-04
WORLDWIDE HEALTHCARE TRUST PLC
S - Sale
-2.03M
$1.00
-2.03M
1
$18.71M
2024-11-27
2024-11-27
LYNX1 CAPITAL MANAGEMENT LP
P - Purchase
Common Stock
29,300
$1.00
29,300
1
$18.71M
2024-11-26
2024-11-27
LYNX1 CAPITAL MANAGEMENT LP
P - Purchase
Common Stock
167K
$1.00
167K
1
$18.71M
2024-11-25
2024-11-27
LYNX1 CAPITAL MANAGEMENT LP
P - Purchase
Common stock, $0.0001 par value per share ("Common Stock")
260K
$1.00
260K
1
$18.71M
2024-09-30
2024-10-02
CALE EDGAR
GC & CORPORATE SECRETARY
A - Grant
Employee Stock Option (right to buy)
50,000
$0.00
1
$18.71M
2024-09-30
2024-10-02
KASSBERG THOMAS RICHARD
A - Grant
Employee Stock Option (right to buy)
174K
$0.00
1
$18.71M
2024-09-19
2024-09-23
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-39,300
$1.00
-39,300
1
$18.71M
2024-09-18
2024-09-18
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-25,631
$1.00
-25,631
1
$18.71M
2024-09-17
2024-09-18
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-111K
$1.00
-111K
1
$18.71M
2024-09-16
2024-09-18
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-63,100
$1.00
-63,100
1
$18.71M
2024-09-16
2024-09-16
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-928K
$1.00
-928K
1
$18.71M
2024-09-16
2024-09-16
WORLDWIDE HEALTHCARE TRUST PLC
S - Sale
-241K
$1.00
-241K
1
$18.71M
2024-05-21
2024-05-23
COUNTOURIOTIS ATHENA
A - Grant
Director Stock Option (right to buy)
47,693
$0.00
1
$18.71M
2024-05-21
2024-05-23
GOWEN MAXINE
A - Grant
Director Stock Option (right to buy)
47,693
$0.00
1
$18.71M
2024-05-21
2024-05-23
ISLAM SAQIB
A - Grant
Director Stock Option (right to buy)
47,693
$0.00
1
$18.71M
2024-05-21
2024-05-23
KAPADIA SANDIP
A - Grant
Director Stock Option (right to buy)
47,693
$0.00
1
$18.71M
2024-05-21
2024-05-23
PORTER DERRELL
A - Grant
Director Stock Option (right to buy)
47,693
$0.00
1
$18.71M
2024-05-21
2024-05-23
SONDHI DOLAN
A - Grant
Director Stock Option (right to buy)
39,092
$0.00
1
$18.71M
2024-03-15
2024-03-19
BORTHWICK KATHLEEN
CFO
A - Grant
Employee Stock Option (right to buy)
227K
$0.00
1
$18.71M
2024-03-15
2024-03-19
CALE EDGAR
GC & CORPORATE SECRETARY
A - Grant
Employee Stock Option (right to buy)
203K
$0.00
1
$18.71M
2024-03-15
2024-03-19
CHOU WILLIAM
PRESIDENT AND CEO
A - Grant
Employee Stock Option (right to buy)
575K
$0.00
1
$18.71M
2024-03-15
2024-03-19
FORMAN MARK
CHIEF MEDICAL OFFICER
A - Grant
Employee Stock Option (right to buy)
203K
$0.00
1
$18.71M
2024-02-13
2024-02-13
FORMAN MARK
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-1,638
$1.00
-1,638
1
$18.71M
2024-02-13
2024-02-13
BORTHWICK KATHLEEN
SVP, INTERIM CFO
S - Sale
Common Stock
-1,470
$1.00
-1,470
1
$18.71M
2024-02-10
2024-02-13
FORMAN MARK
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
5,000
1
$18.71M
2024-02-10
2024-02-13
BORTHWICK KATHLEEN
SVP, INTERIM CFO
M - Exercise
Restricted Stock Unit
-4,000
$0.00
1
$18.71M
2024-02-10
2024-02-13
BORTHWICK KATHLEEN
SVP, INTERIM CFO
M - Exercise
Common Stock
4,000
1
$18.71M
2024-02-10
2024-02-13
FORMAN MARK
CHIEF MEDICAL OFFICER
M - Exercise
Restricted Stock Unit
-5,000
$0.00
1
$18.71M
2022-02-10
2024-02-13
FORMAN MARK
CHIEF MEDICAL OFFICER
A - Grant
Employee Stock Option (right to buy)
25,000
$0.00
1
$18.71M
2022-02-10
2024-02-13
FORMAN MARK
CHIEF MEDICAL OFFICER
A - Grant
Restricted Stock Unit
15,000
$0.00
1
$18.71M
2021-08-16
2024-02-13
FORMAN MARK
CHIEF MEDICAL OFFICER
A - Grant
Employee Stock Option (right to buy)
130K
$0.00
1
$18.71M
2024-01-02
2024-01-03
FORMAN MARK
Chief Medical Officer
S - Sale
Common Stock
-15,813
$1.00
-15,813
1
$18.71M
2024-01-02
2024-01-03
BORTHWICK KATHLEEN
SVP, Interim CFO
S - Sale
Common Stock
-10,672
$1.00
-10,672
1
$18.71M
2024-01-02
2024-01-03
CALE EDGAR
GC & Corporate Secretary
S - Sale
Common Stock
-15,813
$1.00
-15,813
1
$18.71M
2023-12-31
2024-01-03
BORTHWICK KATHLEEN
SVP, Interim CFO
M - Exercise
Common Stock
30,000
1
$18.71M
2023-12-31
2024-01-03
FORMAN MARK
Chief Medical Officer
M - Exercise
Restricted Stock Unit
-50,000
$0.00
1
$18.71M
2023-12-31
2024-01-03
FORMAN MARK
Chief Medical Officer
M - Exercise
Common Stock
50,000
1
$18.71M
2023-12-31
2024-01-03
BORTHWICK KATHLEEN
SVP, Interim CFO
M - Exercise
Restricted Stock Unit
-30,000
$0.00
1
$18.71M
2023-12-31
2024-01-03
CALE EDGAR
GC & Corporate Secretary
M - Exercise
Restricted Stock Unit
-50,000
$0.00
1
$18.71M
2023-12-31
2024-01-03
CALE EDGAR
GC & Corporate Secretary
M - Exercise
Common Stock
50,000
1
$18.71M
2023-07-28
2023-08-01
KING SIMONA
Chief Financial Officer
M - Exercise
Common Stock
31,250
$0.00
1
$18.71M
2023-07-28
2023-08-01
KING SIMONA
Chief Financial Officer
S - Sale
Common Stock
-11,453
$1.00
-11,453
1
$18.71M
2023-07-28
2023-08-01
KING SIMONA
Chief Financial Officer
M - Exercise
Restricted Stock Units
-31,250
$0.00
1
$18.71M
2023-07-27
2023-07-31
SONDHI DOLAN
A - Grant
Director Stock Option (right to buy)
48,000
$0.00
1
$18.71M
2023-07-28
2023-07-28
BORTHWICK KATHLEEN
SVP, Interim CFO
A - Grant
Employee Stock Option (right to buy)
20,000
$0.00
1
$18.71M
2023-06-28
2023-06-29
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
575K
$1.00
575K
1
$18.71M
2023-06-27
2023-06-29
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
617K
$1.00
617K
1
$18.71M
2023-06-16
2023-06-20
FOTOPOULOS ALEXANDROS
Chief Technical Officer
S - Sale
Common Stock
-4,052
$1.00
-4,052
1
$18.71M
2023-06-15
2023-06-20
FOTOPOULOS ALEXANDROS
Chief Technical Officer
M - Exercise
Common Stock
12,500
$0.00
1
$18.71M
2023-06-15
2023-06-20
FOTOPOULOS ALEXANDROS
Chief Technical Officer
M - Exercise
Restricted Stock Units
-12,500
$0.00
1
$18.71M
2023-05-25
2023-05-26
WOIWODE THOMAS
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2023-05-25
2023-05-26
COUNTOURIOTIS ATHENA
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2023-05-25
2023-05-26
GOWEN MAXINE
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2023-05-25
2023-05-26
ISLAM SAQIB
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2023-05-25
2023-05-26
KAMARCK MICHAEL
A - Grant
Director Stock Option (Right to Buy)
21,567
$0.00
1
$18.71M
2023-05-25
2023-05-26
KAPADIA SANDIP
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2023-05-25
2023-05-26
PORTER DERRELL
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2023-04-18
2023-04-20
KING SIMONA
Chief Financial Officer
M - Exercise
Restricted Stock Units
-6,250
$0.00
1
$18.71M
2023-04-18
2023-04-20
KING SIMONA
Chief Financial Officer
M - Exercise
Common Stock
6,250
$0.00
1
$18.71M
2023-04-18
2023-04-20
KING SIMONA
Chief Financial Officer
S - Sale
Common Stock
-2,053
$1.00
-2,053
1
$18.71M
2023-03-15
2023-04-05
CALE EDGAR
GC & Corporate Secretary
A - Grant
Employee Stock Option (right to buy)
175K
$0.00
1
$18.71M
2023-03-15
2023-04-05
CHOU WILLIAM
President and CEO
A - Grant
Employee Stock Option (right to buy)
609K
$0.00
1
$18.71M
2023-03-15
2023-04-05
FORMAN MARK
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
175K
$0.00
1
$18.71M
2023-03-15
2023-04-05
FOTOPOULOS ALEXANDROS
Chief Technical Officer
A - Grant
Employee Stock Option (right to buy)
175K
$0.00
1
$18.71M
2023-03-15
2023-04-05
KING SIMONA
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
140K
$0.00
1
$18.71M
2022-12-01
2022-12-02
KAPADIA SANDIP
S - Sale
Common Stock
-5,000
$1.00
-5,000
1
$18.71M
2022-11-22
2022-11-25
FOTOPOULOS ALEXANDROS
Chief Technical Officer
M - Exercise
Restricted Stock Units
-12,500
$0.00
1
$18.71M
2022-11-22
2022-11-25
FOTOPOULOS ALEXANDROS
Chief Technical Officer
M - Exercise
Common Stock
12,500
$0.00
1
$18.71M
2022-11-22
2022-11-25
FOTOPOULOS ALEXANDROS
Chief Technical Officer
S - Sale
Common Stock
-3,720
$1.00
-3,720
1
$18.71M
2022-09-19
2022-11-18
TOERNSEN MONIKA MARIA
Chief Commercial Officer
S - Sale
Common Stock
-1,681
$2.00
-3,362
1
$18.71M
2022-09-15
2022-11-18
TOERNSEN MONIKA MARIA
Chief Commercial Officer
M - Exercise
Common Stock
5,000
1
$18.71M
2022-09-15
2022-11-18
TOERNSEN MONIKA MARIA
Chief Commercial Officer
M - Exercise
Restricted Stock Unit
-5,000
$0.00
1
$18.71M
2022-11-10
2022-11-14
CALE EDGAR
GC & Corporate Secretary
A - Grant
Restricted Stock Unit
50,000
$0.00
1
$18.71M
2022-11-10
2022-11-14
FORMAN MARK
Chief Medical Officer
A - Grant
Restricted Stock Unit
50,000
$0.00
1
$18.71M
2022-11-10
2022-11-14
FOTOPOULOS ALEXANDROS
Chief Technical Officer
A - Grant
Restricted Stock Unit
50,000
$0.00
1
$18.71M
2022-11-10
2022-11-14
KING SIMONA
Chief Financial Officer
A - Grant
Restricted Stock Unit
50,000
$0.00
1
$18.71M
2022-10-10
2022-10-12
CHOU WILLIAM
Chief Executive Officer
A - Grant
Employee Stock Option (right to buy)
885K
$0.00
1
$18.71M
2022-07-05
2022-07-06
KAMARCK MICHAEL
A - Grant
Stock Option (right to buy)
48,000
$0.00
1
$18.71M
2022-06-13
2022-06-15
CALE EDGAR
Interim CEO, GC & Corp. Sec.
A - Grant
Employee Stock Option (right to buy)
106K
$0.00
1
$18.71M
2022-06-13
2022-06-15
FORMAN MARK
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
136K
$0.00
1
$18.71M
2022-06-13
2022-06-15
FOTOPOULOS ALEXANDROS
Chief Technical Officer
A - Grant
Employee Stock Option (right to buy)
200K
$0.00
1
$18.71M
2022-06-13
2022-06-15
KING SIMONA
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
159K
$0.00
1
$18.71M
2022-06-13
2022-06-15
TOERNSEN MONIKA MARIA
Chief Commercial Officer
A - Grant
Employee Stock Option (right to buy)
101K
$0.00
1
$18.71M
2022-05-31
2022-06-01
GOWEN MAXINE
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$18.71M
2022-05-31
2022-06-01
CALE EDGAR
Interim CEO, GC & Corp. Sec.
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$18.71M
2022-05-27
2022-06-01
GOLDSMITH BRUCE
CEO and President
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$18.71M
2022-05-26
2022-05-31
GOWEN MAXINE
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2022-05-26
2022-05-31
COUNTOURIOTIS ATHENA
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2022-05-26
2022-05-31
ISLAM SAQIB
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2022-05-26
2022-05-31
KAPADIA SANDIP
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2022-05-26
2022-05-31
PORTER DERRELL
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2022-05-26
2022-05-31
WOIWODE THOMAS
A - Grant
Director Stock Option (Right to Buy)
24,000
$0.00
1
$18.71M
2022-05-04
2022-05-05
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
304K
$2.00
607K
1
$18.71M
2022-05-03
2022-05-05
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
222K
$2.00
443K
1
$18.71M
2022-01-20
2022-05-05
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
50,800
$5.00
254K
1
$18.71M
2022-04-18
2022-04-20
FORMAN MARK
Chief Medical Officer
A - Grant
Employee Stock Options (right to buy)
136K
$0.00
1
$18.71M
2022-04-18
2022-04-20
KING SIMONA
Chief Financial Officer
A - Grant
Restricted Stock Unit
25,000
$0.00
1
$18.71M
2022-03-21
2022-03-23
GOLDSMITH BRUCE
CEO and President
P - Purchase
Common Stock
10,000
$3.00
30,000
1
$18.71M
2022-02-10
2022-02-14
FOTOPOULOS ALEXANDROS
Chief Technical Officer
A - Grant
Stock Option (right to buy)
164K
$0.00
1
$18.71M
2022-02-10
2022-02-14
CALE EDGAR
GC and Corporate Secretary
A - Grant
Stock Option (right to buy)
106K
$0.00
1
$18.71M
2022-02-10
2022-02-14
GOLDSMITH BRUCE
CEO and President
A - Grant
Stock Option (right to buy)
400K
$0.00
1
$18.71M
2022-02-10
2022-02-14
KING SIMONA
Chief Financial Officer
A - Grant
Stock Option (right to buy)
159K
$0.00
1
$18.71M
2022-02-10
2022-02-14
SALINAS ELISEO ORESTE
Chief Res. & Develop Officer
A - Grant
Stock Option (right to buy)
158K
$0.00
1
$18.71M
2022-02-10
2022-02-14
TOERNSEN MONIKA MARIA
Chief Commercial Officer
A - Grant
Stock Option (right to buy)
101K
$0.00
1
$18.71M
2022-01-20
2022-01-24
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
369K
$5.00
1.85M
1
$18.71M
2022-01-19
2022-01-20
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
43,300
$5.00
217K
1
$18.71M
2022-01-18
2022-01-20
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
115K
$5.00
574K
1
$18.71M
2022-01-14
2022-01-20
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
10,300
$6.00
61,800
1
$18.71M
2022-01-13
2022-01-13
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
41,800
$6.00
251K
1
$18.71M
2022-01-12
2022-01-13
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
100K
$6.00
600K
1
$18.71M
2022-01-11
2022-01-13
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
8,200
$6.00
49,200
1
$18.71M
2021-12-08
2021-12-10
QUIGLEY JILL
Chief Operating Officer
M - Exercise
Employee Stock Option (right to buy)
-71,975
$0.00
2
$18.71M
2021-12-08
2021-12-10
QUIGLEY JILL
Chief Operating Officer
M - Exercise
Common Stock
71,975
$0.00
1
$18.71M
2021-08-23
2021-08-25
KING SIMONA
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
360K
$0.00
1
$18.71M
2021-07-19
2021-07-21
TOERNSEN MONIKA MARIA
Chief Commercial Officer
A - Grant
Employee Stock Option (Right to Buy)
200K
$0.00
1
$18.71M
2021-07-19
2021-07-21
TOERNSEN MONIKA MARIA
Chief Commercial Officer
A - Grant
Restricted Stock Units
20,000
$0.00
1
$18.71M
2021-05-27
2021-06-01
GOWEN MAXINE
A - Grant
Director Stock Option (Right to Buy)
4,542
$0.00
1
$18.71M
2021-05-27
2021-05-28
COUNTOURIOTIS ATHENA
A - Grant
Director Stock Option (Right to Buy)
16,918
$0.00
1
$18.71M
2021-05-27
2021-05-28
ISLAM SAQIB
A - Grant
Director Stock Option (Right to Buy)
16,918
$0.00
1
$18.71M
2021-05-27
2021-05-28
KAPADIA SANDIP
A - Grant
Director Stock Option (Right to Buy)
16,918
$0.00
1
$18.71M
2021-05-27
2021-05-28
PORTER DERRELL
A - Grant
Director Stock Option (Right to Buy)
33,836
$0.00
1
$18.71M
2021-05-27
2021-05-28
RATCLIFFE LIAM
A - Grant
Director Stock Option (Right to Buy)
16,918
$0.00
1
$18.71M
2021-05-27
2021-05-28
WOIWODE THOMAS
A - Grant
Director Stock Option (Right to Buy)
16,918
$0.00
1
$18.71M
2021-05-27
2021-05-28
YAMADA TADATAKA
A - Grant
Director Stock Option (Right to Buy)
16,918
$0.00
1
$18.71M
2021-05-21
2021-05-21
GOLDSMITH BRUCE
CEO and President
P - Purchase
Common Stock
2,000
$13.00
26,000
1
$18.71M
2021-05-21
2021-05-21
MORRIS RICHARD STEVEN
Chief Financial Officer
P - Purchase
Common Stock
2,171
$14.00
30,394
1
$18.71M
2021-05-17
2021-05-19
FOTOPOULOS ALEXANDROS
Chief Technical Officer
A - Grant
Restricted Stock Unit (RSU)
50,000
$0.00
1
$18.71M
2021-03-22
2021-03-29
SALINAS ELISEO ORESTE
Chief Res. & Develop Officer
A - Grant
Employee Stock Option (Right to buy)
275K
$0.00
1
$18.71M
2021-03-22
2021-03-29
SALINAS ELISEO ORESTE
Chief Res. & Develop Officer
A - Grant
Restricted Stock Unit (RSU)
100K
$0.00
2
$18.71M
2021-03-15
2021-03-17
ROMANO GARY
Chief Medical Officer
M - Exercise
Employee Stock Option (right to buy)
-10,000
$0.00
1
$18.71M
2021-03-15
2021-03-17
ROMANO GARY
Chief Medical Officer
M - Exercise
Common Stock
10,000
$8.00
80,000
1
$18.71M
2021-03-15
2021-03-17
ROMANO GARY
Chief Medical Officer
S - Sale
Common Stock
-10,000
$21.00
-210K
2
$18.71M
2021-02-18
2021-02-22
GOWEN MAXINE
A - Grant
Stock Option (right to buy)
33,836
$0.00
1
$18.71M
2021-02-16
2021-02-18
CALE EDGAR
GC and Corporate Secretary
A - Grant
Stock Option (right to buy)
171K
$0.00
1
$18.71M
2021-02-16
2021-02-18
FOTOPOULOS ALEXANDROS
Chief Technical Officer
A - Grant
Stock Option (right to buy)
105K
$0.00
1
$18.71M
2021-02-16
2021-02-18
GOLDSMITH BRUCE
CEO and President
A - Grant
Stock Option (right to buy)
262K
$0.00
1
$18.71M
2021-02-16
2021-02-18
MORRIS RICHARD STEVEN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
50,000
$0.00
1
$18.71M
2021-02-16
2021-02-18
QUIGLEY JILL
Chief Operating Officer
A - Grant
Stock Option (right to buy)
105K
$0.00
1
$18.71M
2021-02-16
2021-02-18
ROMANO GARY
Chief Medical Officer
A - Grant
Stock Option (right to buy)
105K
$0.00
1
$18.71M
2021-01-20
2021-01-22
QUIGLEY JILL
Chief Operating Officer
S - Sale
Common Stock
-1,300
$30.00
-39,000
1
$18.71M
2021-01-14
2021-01-15
QUIGLEY JILL
Chief Operating Officer
S - Sale
Common Stock
16,298
$30.00
489K
1
$18.71M
2020-03-24
2020-03-25
COUNTOURIOTIS ATHENA
P - Purchase
Common Stock
10,000
$15.00
150K
1
$18.71M
2020-03-03
2020-03-13
RATCLIFFE LIAM
C - Conversion
Series B Preferred Stock
-2.07M
$0.00
1
$18.71M
2020-03-03
2020-03-13
RATCLIFFE LIAM
C - Conversion
Common Stock
2.07M
1
$18.71M
2020-03-03
2020-03-13
RATCLIFFE LIAM
P - Purchase
Common Stock
553K
$18.00
9.95M
2
$18.71M
2020-03-03
2020-03-03
FRAZIER LIFE SCIENCES IX, L.P.
C - Conversion
Common Stock
4.46M
3
$18.71M
2020-03-03
2020-03-03
HERON PATRICK
C - Conversion
Series A-1 Preferred Stock
-2.98M
$0.00
1
$18.71M
2020-03-03
2020-03-03
HERON PATRICK
C - Conversion
Series A-2 Preferred Stock
-1.05M
$0.00
1
$18.71M
2020-03-03
2020-03-03
HERON PATRICK
C - Conversion
Series B Preferred Stock
-433K
$0.00
1
$18.71M
2020-03-03
2020-03-03
HERON PATRICK
C - Conversion
Common Stock
4.46M
3
$18.71M
2020-03-03
2020-03-03
FRAZIER LIFE SCIENCES IX, L.P.
C - Conversion
Series A-1 Preferred Stock
-2.98M
$0.00
1
$18.71M
2020-03-03
2020-03-03
FRAZIER LIFE SCIENCES IX, L.P.
C - Conversion
Series A-2 Preferred Stock
-1.05M
$0.00
1
$18.71M
2020-03-03
2020-03-03
FRAZIER LIFE SCIENCES IX, L.P.
C - Conversion
Series B Preferred Stock
-433K
$0.00
1
$18.71M
2020-03-03
2020-03-03
WOIWODE THOMAS
C - Conversion
Common Stock
4.73M
3
$18.71M
2020-03-03
2020-03-03
CALE EDGAR
GC and Corporate Secretary
P - Purchase
Common Stock
2,000
$18.00
36,000
1
$18.71M
2020-03-03
2020-03-03
COUNTOURIOTIS ATHENA
P - Purchase
Common Stock
8,900
$18.00
160K
1
$18.71M
2020-03-03
2020-03-03
FOTOPOULOS ALEXANDROS
Chief Technical Officer
P - Purchase
Common Stock
5,500
$18.00
99,000
1
$18.71M
2020-03-03
2020-03-03
FRAZIER LIFE SCIENCES IX, L.P.
P - Purchase
Common Stock
550K
$18.00
9.90M
1
$18.71M
2020-03-03
2020-03-03
GOLDSMITH BRUCE
CEO and President
P - Purchase
Common Stock
1,100
$18.00
19,800
1
$18.71M
2020-03-03
2020-03-03
HERON PATRICK
P - Purchase
Common Stock
550K
$18.00
9.90M
1
$18.71M
2020-03-03
2020-03-03
ISLAM SAQIB
P - Purchase
Common Stock
5,000
$18.00
90,000
1
$18.71M
2020-03-03
2020-03-03
KAPADIA SANDIP
P - Purchase
Common Stock
5,000
$18.00
90,000
1
$18.71M
2020-03-03
2020-03-03
MORRIS RICHARD STEVEN
Chief Financial Officer
P - Purchase
Common Stock
400
$18.00
7,200
1
$18.71M
2020-03-03
2020-03-03
QUIGLEY JILL
Chief Operating Officer
P - Purchase
Common Stock
2,500
$18.00
45,000
2
$18.71M
2020-03-03
2020-03-03
RATCLIFFE LIAM
P - Purchase
Common Stock
2,800
$18.00
50,400
1
$18.71M
2020-03-03
2020-03-03
VERSANT VENTURE CAPITAL VI, L.P.
P - Purchase
Common Stock
225K
$18.00
4.05M
1
$18.71M
2020-03-03
2020-03-03
WOIWODE THOMAS
P - Purchase
Common Stock
225K
$18.00
4.05M
1
$18.71M
2020-03-03
2020-03-03
YAMADA TADATAKA
P - Purchase
Common Stock
6,500
$18.00
117K
1
$18.71M
2020-03-03
2020-03-03
ORBIMED ADVISORS LLC
C - Conversion
Series A-1 Preferred Stock
-3.72M
$0.00
1
$18.71M
2020-03-03
2020-03-03
ORBIMED ADVISORS LLC
C - Conversion
Series A-2 Preferred Stock
-1.31M
$0.00
1
$18.71M
2020-03-03
2020-03-03
ORBIMED ADVISORS LLC
C - Conversion
Series B Preferred Stock
-541K
$0.00
1
$18.71M
2020-03-03
2020-03-03
ORBIMED ADVISORS LLC
C - Conversion
Common Stock
5.57M
3
$18.71M
2020-03-03
2020-03-03
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series A-1 Preferred Stock
-2.98M
$0.00
1
$18.71M
2020-03-03
2020-03-03
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series A-2 Preferred Stock
-1.05M
$0.00
1
$18.71M
2020-03-03
2020-03-03
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series B Preferred Stock
-708K
$0.00
1
$18.71M
2020-03-03
2020-03-03
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Common Stock
4.73M
3
$18.71M
2020-03-03
2020-03-03
WOIWODE THOMAS
C - Conversion
Series A-1 Preferred Stock
-2.98M
$0.00
1
$18.71M
2020-03-03
2020-03-03
WOIWODE THOMAS
C - Conversion
Series A-2 Preferred Stock
-1.05M
$0.00
1
$18.71M
2020-03-03
2020-03-03
WOIWODE THOMAS
C - Conversion
Series B Preferred Stock
-708K
$0.00
1
$18.71M
2020-02-28
2020-03-03
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
373K
$18.00
6.72M
1
$18.71M
2020-02-27
2020-03-02
FOTOPOULOS ALEXANDROS
Chief Technical Officer
A - Grant
Employee Stock Option (Right to Buy)
74,311
$0.00
1
$18.71M
2020-02-27
2020-03-02
HERON PATRICK
A - Grant
Director Stock Option (Right to Buy)
33,836
$0.00
1
$18.71M
2020-02-27
2020-03-02
ISLAM SAQIB
A - Grant
Director Stock Option (Right to Buy)
16,918
$0.00
1
$18.71M
2020-02-27
2020-03-02
KAPADIA SANDIP
A - Grant
Director Stock Option (Right to Buy)
16,918
$0.00
1
$18.71M
2020-02-27
2020-03-02
MORRIS RICHARD STEVEN
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
74,311
$0.00
1
$18.71M
2020-02-27
2020-03-02
QUIGLEY JILL
Chief Operating Officer
A - Grant
Employee Stock Option (Right to Buy)
211K
$0.00
1
$18.71M
2020-02-27
2020-03-02
RATCLIFFE LIAM
A - Grant
Director Stock Option (Right to Buy)
33,836
$0.00
1
$18.71M
2020-02-27
2020-03-02
ROMANO GARY
Chief Medical Officer
A - Grant
Employee Stock Option (Right to Buy)
74,311
$0.00
1
$18.71M
2020-02-27
2020-03-02
SQUINTO STEPHEN
Head of Research and Dev
A - Grant
Director Stock Option (Right to Buy)
33,836
$0.00
1
$18.71M
2020-02-27
2020-03-02
SQUINTO STEPHEN
Head of Research and Dev
A - Grant
Employee Stock Option (Right to Buy)
186K
$0.00
1
$18.71M
2020-02-27
2020-03-02
WOIWODE THOMAS
A - Grant
Director Stock Option (Right to Buy)
33,836
$0.00
1
$18.71M
2020-02-27
2020-03-02
YAMADA TADATAKA
A - Grant
Director Stock Option (Right to Buy)
33,836
$0.00
1
$18.71M
2020-02-27
2020-03-02
CALE EDGAR
GC and Corporate Secretary
A - Grant
Employee Stock Option (Right to Buy)
99,731
$0.00
1
$18.71M
2020-02-27
2020-03-02
COUNTOURIOTIS ATHENA
A - Grant
Director Stock Option (Right to Buy)
33,836
$0.00
1
$18.71M